Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study-Reference-Cited by-同舟云学术

Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study

Published:2018-11 Issue:11 Volume:20 Page:1346-1353
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Costa Jean-Marc,Letourneau Alexandra,Favre Romain,Bidat Laurent,Belaisch-Allart Joelle,Jouannic Jean-Marie,Quarello Edwin,Senat Marie-Victoire,Broussin Bernard,Tsatsaris Vassilis,Demain Adèle,Kleinfinger Pascale,Lohmann Laurence,Agostini Hélène,Bouyer Jean,Benachi Alexandra

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim20184.pdf

Reference37 articles.

1. Rapport médical et scientifique de l’Agence de la Biomédecine.2015. https://agence-biomedecine.fr.

2. SMFM statement: clarification of recommendations regarding cell-free DNA aneuploidy screening. Am J Obstet Gynecol 2015;231:753–754.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of retest reliability for pregnant women undergoing cfDNA testing with a no-call result;Molecular Biology Reports;2023-08-03

2. cffDNA Testing in IVF Pregnancies;Prenatal Diagnostic Testing for Genetic Disorders;2023

3. Cell-free fetal DNA testing performance and fetal fraction estimation are not affected in ART-conceived pregnancies;Human Reproduction;2022-10-12

4. Non-invasive Prenatal Testing in Pregnancies Following Assisted Reproduction;Current Genomics;2022-08

5. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies;Genetics in Medicine;2022-07